Your Periods Are Irregular, Yet Everything Comes Back Normal. Here's the Biological Reason.

ESR1 encodes the estrogen receptor alpha, the primary receptor that allows your cells to respond to estrogen signaling. When estrogen binds to this receptor, it triggers a cascade of effects: bone building, mood regulation, cardiovascular protection, and most directly relevant to your cycle, the development of the uterine lining and the hormonal feedback loops that coordinate your menstrual rhythm.

The PvuII and XbaI variants in ESR1 affect how efficiently estrogen can bind to and activate this receptor. Roughly 40% of the population carries variants that reduce receptor sensitivity. If you have reduced ESR1 sensitivity, your cells need higher circulating estrogen to trigger the same biological response that someone with normal sensitivity gets from baseline levels. Yet your bloodwork shows normal estrogen. This is the mismatch.

What this means for your cycle: your uterine lining may not thicken predictably because your cells aren’t hearing the estrogen signal clearly. Your FSH and LH feedback loops may not sync properly, causing irregular ovulation or absent ovulation. You might skip a period, then have a heavy one, then a light one. Your cycle length varies wildly. And your doctor sees normal hormone levels and has no explanation.

CYP19A1 encodes aromatase, the enzyme responsible for converting testosterone to estrogen. In women, this conversion happens primarily in fat tissue, ovarian granulosa cells, and bone. This is your body’s main mechanism for producing circulating estrogen after ovulation.

Variants in CYP19A1 affect aromatase activity. The most studied is the TTTA repeat polymorphism; fewer repeats correlate with higher aromatase activity, more repeats with lower activity. This is a common variant with population-wide variation. If you carry variants associated with lower aromatase activity, your body converts testosterone to estrogen inefficiently, meaning you produce less circulating estrogen despite normal testosterone levels. Your total hormone production is insufficient, even though individual hormones appear normal in isolation.

For your cycle, this means inadequate estrogen to drive the proliferative phase, irregular ovulation timing, and potentially anovulatory cycles (periods without ovulation). You might have light periods or miss periods entirely because there was no ovulation to trigger progesterone production and the subsequent shedding.

COMT (catechol-O-methyltransferase) is famous for its role in clearing dopamine, norepinephrine, and epinephrine, but it also methylates estrogen and its metabolites. This enzyme is your primary mechanism for inactivating and preparing hormones for excretion. When COMT works efficiently, hormones move through your system, do their job, and exit. When it’s slow, they stick around.

The Val158Met variant determines COMT activity. Roughly 25% of people of European ancestry are homozygous slow (Met/Met). If you’re a slow metabolizer, estrogen and its metabolites accumulate in your bloodstream, extending hormonal effects beyond their intended window. This disrupts the precise timing of FSH and LH surges that trigger ovulation. Your body can’t clear one hormonal message before the next one arrives.

You experience this as cycle unpredictability: some months you ovulate on day 12, other months day 18. Your luteal phase is inconsistent. You might have a 50-day cycle followed by a 22-day cycle. Your PMS might be severe because excess circulating estrogen amplifies mood sensitivity. And your estrogen is normal on bloodwork because the test is a snapshot, not a measure of cumulative exposure over the month.

MTHFR (methylenetetrahydrofolate reductase) catalyzes a critical step in the methylation cycle, converting folate into its active form (methylfolate). This active folate is essential for methylating estrogen metabolites so they can be excreted and recycled. MTHFR also supplies methylation capacity for dozens of other pathways, including the methylation of neurotransmitters and DNA itself.

The C677T variant reduces MTHFR enzyme activity by roughly 40-70%. Approximately 40% of people of European ancestry carry at least one copy. If you carry this variant, your cells struggle to methylate estrogen metabolites, causing them to recirculate and persist longer in your system. This overlaps with slow COMT issues but operates through a different mechanism: your body can’t properly package hormones for excretion.

For cycle health, this means accumulated estrogen and estrogen metabolites that interfere with the tight feedback loops controlling FSH, LH, and ovulation timing. You get irregular ovulation, irregular flow, and sometimes a pattern where every other cycle is normal but alternating cycles are disrupted. Your progesterone might be low because you didn’t ovulate clearly, or it might be produced but then not properly metabolized.

VDR (vitamin D receptor) is the cellular receptor that allows your cells to respond to vitamin D signaling. Vitamin D itself is a hormone, and the VDR is how cells hear that signal. VDR variants affect receptor function and expression. This has downstream effects on calcium absorption, immune regulation, and notably, on estrogen receptor sensitivity and ovulatory signaling in the ovary.

The most studied variants are FokI, BsmI, ApaI, and TaqI. Roughly 20-30% of the population carries variants associated with lower VDR expression or function. If you have VDR variants, your cells don’t respond as effectively to vitamin D, meaning you need higher circulating vitamin D levels to achieve the same biological effect. This affects estrogen receptor function because vitamin D acts as a cofactor stabilizing estrogen receptor on DNA.

Your cycle becomes irregular because ovarian follicle development is vitamin D dependent. Without adequate vitamin D signaling through VDR, follicle maturation slows, ovulation timing becomes unpredictable, and luteal phase progesterone production may be insufficient. You might have anovulatory cycles or long follicular phases followed by short luteal phases.

SHBG (sex hormone-binding globulin) is a carrier protein that binds to estrogen and testosterone in your bloodstream. When a hormone is bound to SHBG, it’s sequestered, unavailable to your cells. Only the free (unbound) hormone can enter cells and activate receptors. SHBG levels vary genetically and environmentally. High SHBG means most of your circulating hormone is locked up and unavailable.

The rs6259 and rs1799941 variants affect SHBG expression. Roughly 30-40% of the population carries variants associated with elevated SHBG production. If you have these variants, a larger fraction of your circulating estrogen and testosterone is bound and unavailable, even though total hormone levels look normal on bloodwork. Your cells are hormone-starved even though your doctor sees adequate hormone levels.

For your cycle, inadequate free hormone means weak follicle development, delayed or absent ovulation, irregular cycle length, and sometimes amenorrhea (missing periods entirely). You might have normal FSH and estrogen on paper but not enough free estrogen at the tissue level to trigger the LH surge that initiates ovulation.